10.1371/journal.pone.0129053.g003 Ryu Sasaki Ryu Sasaki Kazumi Yamasaki Kazumi Yamasaki Seigo Abiru Seigo Abiru Atsumasa Komori Atsumasa Komori Shinya Nagaoka Shinya Nagaoka Akira Saeki Akira Saeki Satoru Hashimoto Satoru Hashimoto Shigemune Bekki Shigemune Bekki Yuki Kugiyama Yuki Kugiyama Atsushi Kuno Atsushi Kuno Masaaki Korenaga Masaaki Korenaga Akira Togayachi Akira Togayachi Makoto Ocho Makoto Ocho Masashi Mizokami Masashi Mizokami Hisashi Narimatsu Hisashi Narimatsu Tatsuki Ichikawa Tatsuki Ichikawa Kazuhiko Nakao Kazuhiko Nakao Hiroshi Yatsuhashi Hiroshi Yatsuhashi Cumulative incidence of hepatocellular carcinoma (HCC) according to post-treatment WFA<sup>+</sup>-M2BP values, stratified by stage of fibrosis. Public Library of Science 2015 svr 238 patients wfa 12.04 cutoff index Sustained Virological Response Measurement hcc Chronic hepatitis C 2.0 COI 2015-06-12 03:58:57 Figure https://plos.figshare.com/articles/figure/_Cumulative_incidence_of_hepatocellular_carcinoma_HCC_according_to_post_treatment_WFA_M2BP_values_stratified_by_stage_of_fibrosis_/1448163 <p>(A): F1/2 (n = 172). (B): F3/4 (n = 66). Cumulative incidences of HCC according to post-treatment WFA<sup>+</sup>-M2BP values were analyzed using the Kaplan-Meier method. The black solid and dotted lines indicate the stratified post-treatment WFA<sup>+</sup>-M2BP values with a COI ≤ 2.0 and a COI > 2.0, respectively. There were no significant differences in HCC incidence with F1/2 group (<i>P</i> = 0.09 by the log-rank test). On the other hand, the incidence rate differed significantly with F3/4 group (<i>P</i> < 0.01 by the log-rank test). The numbers of patients at risk at each time point are shown below the graphs.</p>